Accuray Restructures Capital and Governance to Boost Flexibility
I'm LongbridgeAI, I can summarize articles.Accuray restructured its capital and governance to enhance financial flexibility. Key moves include issuing $55M in Series A convertible preferred stock, securing a $5M delayed draw term loan, implementing a covenant holiday through 2027, and executing a reverse stock split. Governance changes involve reducing the board to seven members, with TCW Asset Management gaining two seats. Operationally, Accuray is advancing a transformation strategy focused on innovation, cost reduction, and market expansion via new technologies and strategic partnerships.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Accuray ( (ARAY) ) just unveiled an announcement.
On July 29, 2026, Accuray executed a series of agreements with primary lender and major shareholder TCW Asset Management to strengthen its balance sheet and governance. The company will issue $55 million of Series A convertible preferred stock, funded by a $15 million cash investment and conversion of $40 million of term-loan debt, while cancelling roughly 27.6 million existing warrants and issuing new low-priced warrants.
These transactions are paired with a covenant holiday on key leverage and coverage ratios through year-end 2027, an additional $5 million delayed draw term loan, conversion of the revolving facility into an asset-based revolver, and a planned reverse stock split, collectively boosting liquidity and financial flexibility. Board size is cut to seven directors, TCW gains two designated seats, and two incumbents resigned, signaling tighter lender influence and a more streamlined governance structure as Accuray advances its multi-phase transformation.
Operationally, Accuray is moving into a second phase of its strategy focused on differentiated innovation, cost reduction, and market expansion, while rolling out internally developed technologies such as ClearRT imaging, Synchrony motion management, and the VOLO software platform across its installed base. At the same time, the company is pursuing strategic partnerships, including non-binding letters of intent with Samsung HME America and RaySearch Laboratories and an expanded collaboration with Tata Consultancy Services, to accelerate innovation, improve performance, and support long-term growth in revenues and margins.
The most recent analyst rating on (ARAY) stock is a Hold
with a $0.35 price target.
To see the full list of analyst forecasts on Accuray stock,
see the ARAY Stock Forecast page.
Spark’s Take on ARAY Stock
According to Spark, TipRanks’ AI Analyst, ARAY is a Neutral.
The score is held down primarily by weakening TTM operating performance (margin compression, larger net loss) and negative operating/free cash flow, alongside a technically weak downtrend. Offsetting factors include improved leverage from reduced debt and evidence of cost-saving execution in the transformation plan, but withdrawn guidance and external disruptions keep visibility and execution risk elevated.
To see Spark’s full report on ARAY stock,
click here.
More about Accuray
Accuray Incorporated is a U.S.-based medical technology company that develops and sells radiation therapy systems for cancer treatment. The company focuses on differentiated imaging, motion management, and software platforms, aiming to improve clinical efficiency, expand treatment capabilities, and enhance patient outcomes for global oncology providers.
Its product portfolio includes ClearRT helical kVCT imaging for volumetric visualization, Synchrony real-time motion management for tracking tumor movement, and the VOLO optimizer and software platform for advanced treatment planning. Accuray markets these technologies through direct and partner-based commercial channels as it pursues a transformation strategy centered on innovation, cost efficiency, and expanded market reach.
Average Trading Volume: 3,451,019
Technical Sentiment Signal: Strong Sell
Current Market Cap: $26.77M
Learn more about ARAY stock on TipRanks’ Stock Analysis page.